Capital Royalty is the latest firm to tap the securitization market to fund venture capital loans to healthcare product and service companies, according to Kroll Bond Rating Agency.

CRG Issue 2015-1 will issue $160 million of 'A-' rated debt secured by a $294 million portfolio of 17 fixed-rate loans. Most of the exposure is to three sectors within healthcare: diagnostic, medical device and pharmaceutical companies.

Subscribe Now

Access to a full range of industry content, analysis and expert commentary.

30-Day Free Trial

No credit card required. Access coverage of the securitization marketplace, including breaking news updated throughout the day.